Isolere Bio Inc.
- UEI
- U9LXLSXNME74
- CAGE
- 7XNG7
- Primary NAICS
- Not on record
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Website
- isolerebio.com
- Founded
- 2017
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
About the company
Isolere Bio Inc. is a biotechnology company that specializes in developing reagents to improve the manufacturability, purity, and quality of advanced therapeutics. Through federal grants, Isolere Bio Inc. has provided scientific research and development services focused on innovative technologies for purification and manufacturing of gene therapy vectors, vaccines, antibodies, and RNA products.
Past federal grants awarded to Isolere Bio Inc. supported the development of non-chromatographic purification methods for viral vectors to address inefficiencies in current manufacturing techniques that lead to low yields. This includes an adenovirus purification process combining affinity capture and phase separation (NSF), a lentiviral vector purification method using an engineered fusion protein (NIH), and an adeno-associated virus purification platform called Viratag involving affinity capture and phase separation (NIH). Additional federal grants have funded development of combined RNA production and purification reagents compatible with in vitro manufacturing (NIH) and monoclonal antibody purification methods (NSF). These federal grants were provided by the National Science Foundation Division of Industrial Innovation, National Institutes of Health National Institute of General Medical Sciences, and other NIH entities under programs supporting small business research, technology development, and translational research.
Quick answers
Is Isolere Bio Inc. registered in SAM.gov?
Isolere Bio Inc.'s SAM.gov registration expired on August 6, 2024.
What is Isolere Bio Inc.'s most recent federal award?
Isolere Bio Inc.'s most recent federal grant award is Sbir phase II: non-chromatographic method for the purification of viral vectors (2132838), from Division of Industrial Innovation, on March 1, 2022.
On GovTribe
See Isolere Bio Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors